EyePoint Pharmaceuticals

SEC Filing Details

Document Details

Form
Filing Date
Mar 2, 2021
Document Date
Feb 28, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EyePoint Pharmaceuticals, Inc.
Filer
Godshall Douglas Evan
EyePoint Pharmaceuticals